These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 27531171

  • 1. Authors' reply.
    Kahaly GJ, Diana T.
    J Endocrinol Invest; 2016 Oct; 39(10):1197-8. PubMed ID: 27531171
    [No Abstract] [Full Text] [Related]

  • 2. Sensitivity of assays for TSH-receptor antibodies.
    Bitcon V, Donnelly J, Kiaei D.
    J Endocrinol Invest; 2016 Oct; 39(10):1195-6. PubMed ID: 27531172
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
    Hirooka Y, Li C, Takagi J, Gotoh M, Habu S, Yasaka-Nomura T, Ishihara R, Nakasone Y, Nakamura R, Morikawa R, Otake K, Nogimori T, Ishizuki Y.
    Int J Clin Pharmacol Res; 2004 Oct; 24(4):111-6. PubMed ID: 15754915
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Spontaneous hypothyroidism in 4 patients with Graves-Basedow disease].
    González-González A, Recio Cordova JM, Aznar Ondoño I, Del Monte Jarabo Bueno M.
    Endocrinol Nutr; 2009 May; 56(5):273-6. PubMed ID: 19627750
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relationship between thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine for Graves' disease: retrospective clinical survey.
    Yoshida K, Aizawa Y, Kaise N, Fukazawa H, Kiso Y, Sayama N, Mori K, Hori H, Abe K.
    J Endocrinol Invest; 1996 Nov; 19(10):682-6. PubMed ID: 9007700
    [Abstract] [Full Text] [Related]

  • 10. Clinical relevance of immunological markers in Graves' disease.
    Mann K, Saller B, Hörmann R.
    Exp Clin Endocrinol; 1991 May; 97(2-3):224-30. PubMed ID: 1680726
    [No Abstract] [Full Text] [Related]

  • 11. [Increased levels of auto-antibodies in thyroid diagnostics: Hashimoto thyroidities or Graves disease?].
    Paschke R.
    Internist (Berl); 2006 Nov; 47(11):1193-4. PubMed ID: 17043781
    [No Abstract] [Full Text] [Related]

  • 12. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
    Schott M, Minich WB, Willenberg HS, Papewalis C, Seissler J, Feldkamp J, Bergmann A, Scherbaum WA, Morgenthaler NG.
    Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
    [Abstract] [Full Text] [Related]

  • 13. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N, Kaneko M, Kitazawa M, Uemura Y, Minagawa S, Miyakoshi M, Kaneko K, Kamoi K.
    J Med Case Rep; 2017 Feb 06; 11(1):32. PubMed ID: 28162094
    [Abstract] [Full Text] [Related]

  • 14. Changing trends for diagnostic methods in Graves disease in Australia: an immunological diagnosis as the emerging preference.
    Hsieh A, Twigg SM, Chua EL.
    Intern Med J; 2017 Dec 06; 47(12):1464-1465. PubMed ID: 29224201
    [No Abstract] [Full Text] [Related]

  • 15. The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves' Disease.
    Cho SW, Bae JH, Noh GW, Kim YA, Moon MK, Park KU, Song J, Yi KH, Park do J, Chung JK, Cho BY, Park YJ.
    PLoS One; 2015 Dec 06; 10(12):e0144599. PubMed ID: 26650844
    [Abstract] [Full Text] [Related]

  • 16. TSH-receptor antibodies in hypothyroid Graves' disease.
    Konishi J, Kasagi K, Hidaka A, Takeuchi R, Iida Y, Nakamura H.
    Exp Clin Endocrinol; 1991 May 06; 97(2-3):303-7. PubMed ID: 1680728
    [No Abstract] [Full Text] [Related]

  • 17. Thyroid controversy--stimulating antibodies.
    Davies TF, Roti E, Braverman LE, DeGroot LJ.
    J Clin Endocrinol Metab; 1998 Nov 06; 83(11):3777-85. PubMed ID: 9814446
    [No Abstract] [Full Text] [Related]

  • 18. Autoantibodies to the TSH receptor.
    Zakarija M, McKenzie JM.
    Exp Clin Endocrinol; 1991 May 06; 97(2-3):165-9. PubMed ID: 1680725
    [No Abstract] [Full Text] [Related]

  • 19. The relationship of thyrotropin receptor antibody levels to the severity of thyroid orbitopathy.
    Shokeir MO, Pudek MR, Katz S, Rootman J, Kendler DL.
    Clin Biochem; 1996 Apr 06; 29(2):187-9. PubMed ID: 8601331
    [No Abstract] [Full Text] [Related]

  • 20. [Anti-TSH receptor antibody (TBII, TSAb)].
    Amino N, Kubota S.
    Nihon Rinsho; 2005 Aug 06; 63 Suppl 8():277-9. PubMed ID: 16149508
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.